Fundraising Fox

Ardigen

Krakow, PL · Founded 2015 · 136 employees on LinkedIn · 1 known investors

Ardigen is an AI-driven Contract Research Organization providing bioinformatics and machine learning solutions to accelerate drug discovery for biotech and pharmaceutical companies. The company leverages artificial intelligence, computational biology, and software engineering to help clients identify drug candidates and increase the probability of clinical success.

AI & Machine LearningBiotechDeep TechDigital Health

Founders & leadership

MJ
Maciej JasińskiinPhD

Board

P
PrzewiezlikowskiFounder, CEO (of Ryvu Therapeutics), President of Supervisory Board

Investors · 1

Pointer.CapitalLewes

In the news

Ardigen has received funding for the development of the AI-powered Microbiome Platform. - Ardigen | Top AI-Powered CRO for Drug Discovery & Clinical Trialsardigen.com · Oct 2021Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapiesprnewswire.com · Sep 2020Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies - Ardigenardigen.com · Sep 2020Selvita and Ardigen will receive funding for the development of an AI-based high-content screening platform - Ardigen | Top AI-Powered CRO for Drug Discovery & Clinical Trialsardigen.com · Apr 2020

Frequently asked questions

What does Ardigen do?
Ardigen is an AI-driven Contract Research Organization providing bioinformatics and machine learning solutions to accelerate drug discovery for biotech and pharmaceutical companies. The company leverages artificial intelligence, computational biology, and software engineering to help clients identify drug candidates and increase the probability of clinical success.
Who are Ardigen's investors?
Ardigen's investors include Pointer.Capital.
Where is Ardigen headquartered?
Ardigen is headquartered in Krakow, PL.